Drugs / hiSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06947746 | May 2025 → Jun 2026 overdue | rheumatoid arthritis | Shanghai Changzheng Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hiSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06947746 ↗ |
| Route | Other | “single intra-articular injection of hiSCs” NCT06947746 ↗ |